Angelica Valderrama Rodríguez I am a Physician and I did the specialization in Clinical Pharmacology via MIR at Hospital Universitari Vall d'Hebron. Institutions of which they are part Tècnic de recerca Commercial and Academic Clinical Research Vall Hebron Institut de Recerca LinkedIn Twitter Email Angelica Valderrama Rodríguez LinkedIn Twitter Email Institutions of which they are part Tècnic de recerca Commercial and Academic Clinical Research Vall Hebron Institut de Recerca I am a Physician and I did the specialization in Clinical Pharmacology via MIR at Hospital Universitari Vall d'Hebron.
I have developed my career in the pharmacovigilance area since 2011. I have worked as a collaborating researcher in some clinical studies and I currently work at VHIR-Academic Research Organization as a Project Manager and Responsible of pharmacoviligance.
Projects Plataforma de soporte para la Investigación Clínica IP: Inmaculada Fuentes Camps Collaborators: Antonio Moreno Galdó, Rafael Simó Canonge, Ariadna Martín Balcells, Mª Eulàlia Molinas Guilera, Olga Sánchez- Maroto Carrizo, Angelica Valderrama Rodríguez, Amaia Latasa Arrazubi, Joan Genescà Ferrer, Gemma Vona Giralt, Paula Isabel Roldan Caballero Funding agency: Instituto de Salud Carlos III Funding: 274920 Reference: PT23/00062 Duration: 01/01/2024 - 31/12/2026 Plataforma ISCIII de soporte para la Investigación Clínica IP: Inmaculada Fuentes Camps Collaborators: Antonio Moreno Galdó, Rafael Simó Canonge, Núria Pérez Picazo, Ariadna Martín Balcells, Olga Sánchez- Maroto Carrizo, Angelica Valderrama Rodríguez, Joan Genescà Ferrer, Gemma Vona Giralt, Paula Isabel Roldan Caballero Funding agency: Instituto de Salud Carlos III Funding: 315150 Reference: PT20/00078 Duration: 01/01/2021 - 31/12/2024 NoCanTher: Nanomedicine Upscaling for Early Clinical Phases of Multimodal Cancer Therapy IP: Simon Schwartz Navarro Collaborators: Joaquin Seras Franzoso, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Olga Sánchez- Maroto Carrizo, Angelica Valderrama Rodríguez Funding agency: EUROPEAN COMMISSION Funding: 630633.55 Reference: NOCANTHER_S.SCHWARTZ_H2020_2015 Duration: 01/04/2016 - 30/09/2021
